… and LMWH for the treatment of VTE associated with cancer (… the rationale and design of
the Hokusai VTE-cancer study and to provide a background for various innovative study design …

… This study provides an opportunity to address the knowledge gaps identified above. In the
… groups of cancer patients enrolled in the Hokusai VTE Cancer study, including patients with …

… management of cancer-associated venous thromboembolism. The aim of this study was to
assess the efficacy and safety of edoxaban … The Hokusai-VTE Cancer trial is currently ongoing …

… In the Hokusai VTE Cancer study, edoxaban was non-inferior to dalteparin for the … of
recurrent venous thromboembolism (VTE) and major bleeding in 1,050 patients with cancer-…

… The Hokusai VTE Cancer trial compared edoxaban with dalteparin for VTE treatment in
patients with active cancer. … of the Hokusai VTE Cancer trial who have made this study possible. …

… the treatment of cancer-associated venous thromboembolism … Hokusai VTE Cancer trial to
compare the oral factor Xa inhibitor edoxaban with subcutaneous dalteparin for the treatment …

… study demonstrated that 12 months of edoxaban treatment … The Hokusai VTE Cancer trial
showed that the rate of major … edoxaban treatment group of cancer-associated VTE. The current …

… A previous phase III trial of edoxaban … the study methods and observation periods made it
impossible to compare our results with those of the Hokusai VTE cancer or SELECT-D studies. …

… their use in such patients. The Hokusai VTE Cancer study shows that edoxaban is non-inferior …
of higher major bleeding namely in patients with gastrointestinal cancer. Although further …

… controlled trial comparing edoxaban with dalteparin for cancer-… study outcomes in the
Hokusai VTE Cancer Study were adjudicated by an independent committee unaware of treatment …